InvestorsHub Logo
Followers 103
Posts 13601
Boards Moderated 1
Alias Born 01/23/2004

Re: None

Thursday, 06/15/2023 10:25:12 AM

Thursday, June 15, 2023 10:25:12 AM

Post# of 39969
Let's see I want to make sure I got this straight

Form 10 filed as promised for the period ending February 2023

Weighted average shares outstanding 310,000,185

Looks like none of the financials include Prodigy of Liberty Health Plus

Item 1.01 Entry into a Material Definitive Agreement.

On January 30, 2023, the Company entered into a Binding Letter of Intent to acquire Prodigy Stem Cell, LLC as a wholly owned subsidiary of the Company.
Item 2.01 Completion of Acquisition or Disposition of Assets.
On March 1, 2023, the Company completed the acquisition of Prodigy Stem Cell, LLC
as a wholly owned subsidiary. Prodigy Stem Cell, LLC is a New Jersey based company focused on sales, marketing, and consulting for regenerative medicines.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 1, 2023,the Company appointed Peter Caruso as a Director of the Company. Mr. Caruso has over 20 years of business development experience and is the Founder of Prodigy Stem Cell, LLC.

Just want to make sure I got this rignt

So Jason' Black"s CNNA went into expert market today.

From today to a max of 60 days Jason Tucker's Prodigy will emerge from expert market a fully SEC reporting company
- a company with it emerges with have a quarter of Prodigy and Liberty's audited financials
- on a higher exchange
- 310,000,185 out standing shares

I don't know about any one else but it sure looks like it will be worth the wait to hold.